新城疫病毒F蛋白细胞融合活性位点中保守氨基酸基因突变分析Mutational Analysis of Conserved Amino Acids on the Active Domain of Newcastle Disease Virus Fusion Protein
王志玉,任桂杰,温红玲,宋艳艳,王桂亭,姚苹,许洪芝,张文强
摘要(Abstract):
为了确定新城疫病毒融合蛋白(F)分子上活性位点中保守氨基酸在F蛋白的细胞融合作用,弄清F细胞融合的分子机理,采用基因定点突变法,创造一个酶切位点,用酶切反应初步筛选突变株,然后用DNA序列分析进一步确定,并于真核细胞内进行表达,Giemsa染色定性和指示基因法定量检测细胞融合功能,荧光强度分析(FACS)检测表达效率情况。结果表明,NDV F第117位苯丙氨酸(F)突变成亮氨酸(L)时对细胞融合作用没有显著影响。R112和K115同为保守序列,分别突变为G时,细胞融合活性只有原来的44%,下降了56%。细胞表面表达效率没有明显的改变。N147突变为K时,细胞融合活性明显下降,只有原来的15%,而细胞表面表达效率没有明显的改变。L154为保守序列,突变为K时,细胞融合活性消失,说明L154是一个非常关键的氨基酸,对维持F蛋白的细胞融合活性非常重要。细胞表面表达效率也有所下降(为原来的94%)。D462属于高度保守氨基酸,当突变为N时,细胞融合活性消失,但经细胞表面表达效率分析证明,此突变蛋白未表达于细胞表面,证明在细胞浆转运至细胞表面的过程中发生了问题。当突变为R和E时,细胞融合活性未发生改变,但细胞表面表达效率有所下降,分别为野毒株的63%和44%。说明NDV F分子上与HN相互作用的特异性区域中的某些保守氨基酸在细胞融合中发挥着重要作用,对F蛋白的折叠、加工、转运等,发挥着不同作用,从而影响F蛋白的细胞融合作用和/或在细胞表面的表达量。
关键词(KeyWords): 副粘病毒;融合蛋白;细胞融合;氨基酸;基因;新城疫病毒
基金项目(Foundation): 国家自然科学基金项目(编号:30270061);; 山东大学创新团队项目
作者(Author): 王志玉,任桂杰,温红玲,宋艳艳,王桂亭,姚苹,许洪芝,张文强
参考文献(References):
- [1]王志玉.副粘病毒融合蛋白活性位点中亮氨酸基因突变分析[J].病毒学报,2000,16(1):12-16.
- [2]Fuerst T R,Niles E G,Studier W F,et al.Eukaryotic transient-expression system based on recombinant vaccinia virus that synthe-sizes bacteriophage T7 RNA polymerase[J].Proc Natl Acad SciUSA,1986,83:8122-8126.
- [3]Deng R,Wang Z,Clichman R L,et al.Glycosylation within anantigenic site on the HN glycoprotein of Newcastle disease virus in-terferes with its role in the promotion of membrane fusion[J].Vi-rology,1994,204:17-26.
- [4]Paterson R G,Johnson M L,Lamb R A.Paramyxovirus fusion(F)protein and hemagglutinin-neuramindase(HN)protein interac-tions:intracellular retention of F and HN does not affect transportof the homotypic HN of F protein[J].Virology,1997,237:1-9.
- [5]Tanabayashi K,Compas R W.Functional interaction of paramyx-ovirus glycoproteins:Identification of a domain in Sendai virus HNwhich promotes cell fusion[J].J Virol,1996,70(9):6112-6118.
- [6]Mirza A M,Deng R,Iorioo R M.Site-directed mutagenesis of aconserved hexapeptide in the paramyxovirus hemagglutinin-neu-raminidase glycoprotein:Effects on antigenic structure and function[J].J Virol,1994,68:5093-5099.
- [7]Deng R,Wang Z,Mirza A M,et al.Localization of a domain onthe paramyxovirus attachment protein required for the promotion ofcellular fusion by its homologous fusion protein spike[J].Virology,1995,209:457-469.
- [8]王志玉.副粘病毒融合蛋白分子上特异性细胞融合作用位点的初步确定[J].中华微生物学和免疫学杂志,2000,20(4):289-292.
- [9]王志玉,于修平.用指示基因法定量分析副粘病毒包膜糖蛋白所致的细胞融合[J].中华实验和临床病毒学杂志,2001,15(2):179-181.
- [10]Stone-Hulslander J,Morrison T G.Detection of an interaction be-tween the HN and F proteins in Newcastle disease virus-infectedcells[J].J Virol,1997,71(9):6287-6295.
- [11]Cobaleda C,Munoz-Barroso I,Sagrera A,et al.Fusogenic activi-ty of reconstituted Newcastle disease virus envelopes:a role for thehemagglutinin-neuraminidase protein in the fusion process[J].IntJ Biochem Cell Biol,2002,34(4):403-413.
- [12]Yao Q,Hu X,Compans R W.Association of the parainfluenzavirus fusion and hemagglutinin-neuramindase glycooproteins on cellsurfaces[J].J Virol,1997,71(1):650-656.
- [13]Gould A R,Kattenbelt J A,Selleck P,et al.Virulent Newcastledisease in Australia:molecular epidemiological analysis of virusesisolated prior to and during the outbreaks of 1998-2000[J].Virus Res,2001,77(1):51-60.
- [14]Ke G M,Liu H J,Lin M Y,et al.Molecular characterization ofNewcastle disease viruses isolated from recent outbreaks in Taiwan[J].J Virol Meth,2001,97(1-2):1-11.